Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-25T13:05:19.815Z Has data issue: false hasContentIssue false
  • English
  • Français

Alendronate-induced chemical laryngitis

Published online by Cambridge University Press:  08 March 2006

M F Bhutta ,
M Rance ,
D Gillett  and
J S Weighill
M F Bhutta
Affiliation:
the Department of Otolaryngology—Head and Neck Surgery, Royal Sussex County Hospital, Eastern Road, Brighton, UK.
M Rance
Affiliation:
the Department of Otolaryngology—Head and Neck Surgery, Royal Sussex County Hospital, Eastern Road, Brighton, UK.
D Gillett
Affiliation:
the Department of Otolaryngology—Head and Neck Surgery, Royal Sussex County Hospital, Eastern Road, Brighton, UK.
J S Weighill
Affiliation:
the Department of Otolaryngology—Head and Neck Surgery, Royal Sussex County Hospital, Eastern Road, Brighton, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

Alendronate is a bisphosphonate used in treating osteoporosis. Its recognized side-effects include oesophageal irritation and ulceration. The authors describe a case of laryngitis induced by transient contact of this medication with the laryngeal mucosa. Successful management of this case is also detailed.

Keywords

AlendronateLaryngitis
Type
Book Review
Information
The Journal of Laryngology & Otology , Volume 119 , Issue 1 , January 2005 , pp. 46 - 47
Copyright
© 2005 Royal Society of Medicine Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)